Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-24
2011-05-24
Chandrakumar, Nizal S (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S087000
Reexamination Certificate
active
07947838
ABSTRACT:
Fluoroalkoxybenzamide compounds which selectively bind Sigma-2 receptors are disclosed. These compounds, when labelled with18F, can be used as radiotracers for imaging of tumors by positron emission tomography (PET). In addition, these compounds, when labelled with123I, can be used as radiotracers for imaging of tumors by single photon emission computed tomography (SPECT). Methods for synthesis of these compounds are also disclosed.
REFERENCES:
patent: 4197243 (1980-04-01), Murakami et al.
patent: 5294621 (1994-03-01), Russell
patent: 6046210 (2000-04-01), Stemp et al.
patent: 6113877 (2000-09-01), Mach et al.
patent: 6447748 (2002-09-01), John et al.
patent: 7659400 (2010-02-01), Mach et al.
patent: 2005/0107398 (2005-05-01), Mach et al.
patent: 2008/0161343 (2008-07-01), Mach et al.
patent: 8-510235 (1996-10-01), None
patent: 11-503754 (1999-03-01), None
patent: 2001-502683 (2001-02-01), None
patent: 94/26314 (1994-11-01), None
patent: 96/32968 (1996-10-01), None
patent: 98/17648 (1998-04-01), None
patent: 2005048810 (2005-06-01), None
International Search Report in the related application PCT/US08/655555 issued on Mar. 3, 2009.
Supplementary Partial European Search Report issued on Oct. 10, 2008, in related application 04817745.5.
Curtet et al, New arylpiperazine derivatives as antagonists of the human cloned 5-HT4 receptor isoforms, J Med Chem, 2000, 43:3761-3769.
Hackling et al, N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands, J Med Chem, 2003, 46:3883-3899.
Leopoldo et al, Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]aryl carboxamides as potent and selective dopamine D3 receptor ligands, J Med Chem, 2002, 45:5727-5735.
International Report on Patentability issued Feb. 6, 2006, in the related application PCT/US04/25304.
Al-Nabulsi I, et al., Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells, Br. J. Cancer, 1999, p. 925-933, vol. 81(6).
Anderson CJ and Welch MJ, Radiometal-labeled agents (non-technetium) for diagnostic imaging, Chem. Rev., 1999, p. 2219-2234, vol. 99(9).
Berardi F, et al., 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity, J. Med. Chem., 2004, p. 2308-2317, vol. 47(9).
Bonhaus DW, et al., [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus, J. Pharmacol. Exp. Ther., 1993, p. 961-970, vol. 267(2).
Bowen WD, et al., Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity, Eur. J. Pharmacol., 1995, p. 257-260, vol. 278(3).
Colabufo NA, et al., Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET, J. Pharm. Pharmacol., 2005, p. 1453-1459, vol. 57(11).
Hou C, et al., Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker, Nucl. Med. Biol., 2006, p. 203-209, vol. 33(2).
Huang Y, et al., Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands, J. Med. Chem., 2001, p. 1815-1826, vol. 44(11).
Jurisson SS and Lydon JD, Potential technetium small molecule radiopharmaceuticals, Chem. Rev., 1999, p. 2205-2218, vol. 99(9).
Kassiou M, et al., Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors, Bioorg. Med. Chem., 2005, p. 3623-3626, vol. 13(11).
Laforest R, et al., MicroPET imaging with nonconventional isotopes, IEEE Transactions on Nuclear Science, 2002, p. 2119-2126, vol. 49(5).
Mach RH, et al., Sigma 2 receptors as potential biomarkers of proliferation in breast cancer, Cancer Res., 1997, p. 156-161, vol. 57(1).
Mach RH, et al., Synthesis of 2-(5-bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)-1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptors, Bioorg. Med. Chem., 2003, p. 225-233, vol. 11(2).
Mach RH, et al., [[(18)F]N-(4′-fluorobenzyl)-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [(18)F]FDG, and [(125)I]IUDR, Nucl. Med. Biol., 2001, p. 451-458, vol. 28(4).
Mach RH, et al., Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands, Bioorg. Med. Chem. Lett, 2004, p. 195-202, vol. 14(1).
Tu Z, et al., Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer, Nucl. Med. Biol., 2005, p. 423-430, vol. 32(5).
Wheeler KT, et al., Sigma-2 receptors as a biomarker of proliferation in solid tumours, Br. J. Cancer, 2000, p. 1223-1232, vol. 82(6).
Xu J, et al., [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe, Eur. J. Pharmacol., 2005, p. 8-17, vol. 525(1-3).
Notification of the First Office Action issued on Dec. 24, 2010, in connection with Japanese Application No. 2006-522145 (Japanese language).
Notification of the First Office Action issued on Dec. 24, 2010, in connection with Japanese Application No. 2006-522145 (English translation).
Anderson A., et al., J. Med. Chem, 44: 3582-3591, 2001.
S. Curtet et al.: New aryl piperazine derivatives as antagonists of the human cloned 5-ht4 receptor isoforms, Journal of Medicinal Chemistry vol. 43, No. 20, 2000, pp. 3761-3769, American Chemical Society, Washington, DC, US.
Leopoldo M et al: Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D3 receptor ligands, Journal of Medicinal Chemistry vol. 45, No. 26, 2002, pp. 5727-5735, American Chemical Society, Washington, DC, US.
Hackling. A., et al: N-(ω-(4-(2-Methoxyphenyl) piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 receptor ligands. Journal of Medicinal Chemistry vol. 46, No. 18, 2003, pp. 3863-3899, American Chemical Society, Washington, DC, US.
Mach, R, et al.: Conformationally-flexible benzamide analogues as dopamine 03 and sigma2 receptor ligands, Bioorganic & Medicinal Chemistry Letters vol. 14, No. 1, pp. 195-202, Elsevier, Inc., New York, NY, US.
Mach Robert
Tu Zhude
Chandrakumar Nizal S
Washington University
Zackson Saul L.
Zackson Law LLC
LandOfFree
Radiolabelled benzamide analogues, their synthesis and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabelled benzamide analogues, their synthesis and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabelled benzamide analogues, their synthesis and use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2650010